Sean E. Browne - Oct 15, 2023 Form 4/A Insider Report for Xtant Medical Holdings, Inc. (XTNT)

Role
President and CEO, Director
Signature
/s/ Amy E. Culbert, attorney-in-fact
Stock symbol
XTNT
Transactions as of
Oct 15, 2023
Transactions value $
-$113,877
Form type
4/A
Date filed
2/16/2024, 04:05 PM
Date Of Original Report
Oct 17, 2023
Previous filing
Aug 17, 2023
Next filing
Apr 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XTNT Common Stock Tax liability -$114K -105K -6.27% $1.08 1.58M Oct 15, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purpose of this Form 4 amendment is to correct the number of shares withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.
F2 Includes 174,216 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 433,024 shares to be issued upon vesting pursuant to restricted stock awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended from time to time, all conditioned upon the Reporting Person remaining an employee of Xtant through the vesting dates.